The estimated Net Worth of Martin Vazquez is at least $987 Thousand dollars as of 1 March 2023. Mr Vazquez owns over 5,000 units of Outset Medical stock worth over $55,137 and over the last 4 years he sold OM stock worth over $235,901. In addition, he makes $695,990 as Chief Operating Officer at Outset Medical.
Mr has made over 30 trades of the Outset Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of OM stock worth $19,400 on 1 March 2023.
The largest trade he's ever made was exercising 24,500 units of Outset Medical stock on 1 February 2023 worth over $95,060. On average, Mr trades about 7,088 units every 27 days since 2020. As of 1 March 2023 he still owns at least 108,112 units of Outset Medical stock.
You can see the complete history of Mr Vazquez stock trades at the bottom of the page.
Martin Vazquez is the Chief Operating Officer at Outset Medical.
As the Chief Operating Officer of Outset Medical, the total compensation of Mr Vazquez at Outset Medical is $695,990. There are 1 executives at Outset Medical getting paid more, with Leslie L. Trigg having the highest compensation of $875,082.
Mr Vazquez is 50, he's been the Chief Operating Officer of Outset Medical since . There are 2 older and 5 younger executives at Outset Medical. The oldest executive at Outset Medical, Inc. is Donald Siemens, 70, who is the Independent Director.
Over the last 5 years, insiders at Outset Medical have traded over $829,589,795 worth of Outset Medical stock and bought 42,000 units worth $1,172,030 . The most active insiders traders include Pincus Llc Warburg, Pincus X, L.P.Warburg Pincu..., and Pincus X, L.P.Wp X Finance,.... On average, Outset Medical executives and independent directors trade stock every 7 days with the average trade being worth of $44,055. The most recent stock trade was executed by Leslie Trigg on 15 August 2024, trading 5,308 units of OM stock currently worth $4,459.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical executives and other stock owners filed with the SEC include: